RNF43 inactivating variants have been reported in several gastro-entero-pancreatic neoplasms, including colon adenocarcinoma, pancreatic adenocarcinoma, and intraductal papillary mucinous neoplasms of the pancreas [49–51]. This evidence concerns the gene RNF43 and pancreatic adenocarcinoma.